FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karl-Heinrich Link

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Marko Kornmann; Martina Kron; Karl-Heinrich Link; Ludger Staib; Thomas Wiegel; Andrea Formentini; Doris Henne-Bruns
Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Andrea Formentini; Harald Fricke; Doris Henne-Bruns; Philipp Braun; Karl-Heinrich Link; Marko Kornmann
Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.
Thomas Weber; Mark Roitman; Karl-Heinrich Link
Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karl-Heinrich Link (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marko Kornmann; Martina Kron; Karl-Heinrich Link; Ludger Staib; Thomas Wiegel; Andrea Formentini; Doris Henne-Bruns
Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Clinical colorectal cancer 2013;12(1):54-61.
2012: Andrea Formentini; Harald Fricke; Doris Henne-Bruns; Philipp Braun; Karl-Heinrich Link; Marko Kornmann
Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.
International journal of colorectal disease 2012;27(10):1369-76.
2012: Thomas Weber; Mark Roitman; Karl-Heinrich Link
Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Clinical colorectal cancer 2012;11(3):167-76.
2012: Marko Kornmann; Martina Kron; Ludger Staib; Kathleen Danenberg; Peter Danenberg; Roland Goeb; Holger Hebart; Doris Henne-Bruns; Karl-Heinrich Link
Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: results of a randomised multicentre trial.
European journal of cancer (Oxford, England : 1990) 2012;48(10):1443-51.
2012: A Tikidzhieva; M von Knebel Doeberitz; Marko Kornmann; Karl-Heinrich Link; S Michel; A Benner; W Dippold; Andrea Formentini; M Kloor
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.
British journal of cancer 2012;106(6):1239-45.
2012: Christopher Cao; Marcello Deraco; JESUS ESQUIVEL; Philippe Gertsch; Olivier Glehen; Santiago González-Moreno; Dragutin Kecmanovic; Stein G Larsen; Søren Laurberg; Edward A Levine; Karl-Heinrich Link; Haile Mahteme; Juan T Melero; Brendan Moran; David L Morris; Pompiliu Piso; Richard B Alexander; Luis G Bayón; Kurt van der Speeten; Tristan D Yan; Antonios-Apostolos K Tentes; Paul H Sugarbaker
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale.
Tumori 2012;98(1):166-71.
2011: Thomas Weber; Karl-Heinrich Link
[Multimodal therapy for colon cancer: state of the art].
Zentralblatt für Chirurgie 2011;136(4):325-33.
2010: Marko Kornmann; Ludger Staib; Thomas Wiegel; Ernst D Kreuser; Martina Kron; W Baumann; Doris Henne-Bruns; Karl-Heinrich Link
Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.
British journal of cancer 2010;103(8):1163-72.
2010: Karl-Heinrich Link; M Kornmann; R Bittner; Ferdinand Köckerling; R Arbogast; I Gastinger; W Heitland; D Henne-Bruns; H Lang; H Lippert; M Mann; H J Meyer; M-J Polonius; S Post; R Raab; T Schiedeck; V Schumpelick
[Quality criteria for treatment of colorectal cancer. From a surgeon's viewpoint].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2010;81(3):222-30.
2008: Marko Kornmann; Andrea Formentini; C Ette; Doris Henne-Bruns; Martina Kron; Silvia Sander; W Baumann; Ernst D Kreuser; Ludger Staib; Karl-Heinrich Link
Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008;34(12):1316-21.
2008: R T Grundmann; P Hermanek; S Merkel; C-T Germer; R T Grundmann; Johann Hauss; D Henne-Bruns; K Herfarth; P Hermanek; U T Hopt; T Junginger; E Klar; J Klempnauer; WH Knapp; M Kraus; H Lang; Karl-Heinrich Link; F Löhe; S Merkel; K J Oldhafer; H-R Raab; H-G Rau; A Reinacher-Schick; J Ricke; J Roder; A-O Schäfer; H J Schlitt; M R Schön; D Stippel; Andrea Tannapfel; K Tatsch; T J Vogl
[Diagnosis and treatment of colorectal liver metastases - workflow].
Zentralblatt für Chirurgie 2008;133(3):267-84.
2005: Karl-Heinrich Link; Marko Kornmann; Ludger Staib; Martin Redenbacher; Martina Kron; Hans G Beger
Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha.
Annals of surgery 2005;242(2):178-87.
2005: Karl-Heinrich Link; T A Sagban; M Mörschel; Klaus Tischbirek; M Holtappels; V Apell; K Zayed; Marko Kornmann; L Staib
Colon cancer: survival after curative surgery.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2005;390(2):83-93.
2004: Mathias Wittau; D Weber; B Reher; Karl-Heinrich Link; Doris Henne-Bruns; Marco Siech
[Emergent surgery for body packing - what happens to the drugs?].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2004;75(4):436-41.
2004: Karl-Heinrich Link; K Happich; Iveta Schirner; Barbara Jüngert; V Brückl; Gudrun Männlein; Wolfgang M Brückl; Susanne Merkel; Jonas Göhl; Werner Hohenberger; Eckhart Hahn; Axel Wein
Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
Anticancer research 2004;24(1):385-91.
2003: Hans G Beger; Bettina Rau; Frank Gansauge; Bertram Poch; Karl-Heinrich Link
Treatment of pancreatic cancer: challenge of the facts.
World journal of surgery 2003;27(10):1075-84.
2003: Marko Kornmann; Wolfgang Schwabe; Silvia Sander; Martina Kron; Jörn Sträter; Sucan Polat; Erika Kettner; Hans F Weiser; Wolfram Baumann; Harald Schramm; Peter Häusler; Kati Ott; Detlev Behnke; Ludger Staib; Hans G Beger; Karl-Heinrich Link
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4116-24.
2003: Karl-Heinrich Link; M Roitman; M Holtappels; I Runnebaum; H Urbanzyk; Gerhard Leder; Ludger Staib
Intraperitoneal chemotherapy with mitoxantrone in malignant ascites.
Surgical oncology clinics of North America 2003;12(3):865-72, xvi-xvii.
2003: E Papachristou; Karl-Heinrich Link; MH Schoenberg
Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.
Anticancer research 2003;23(2A):831-4.
2003: Brigitta U M Monz; Hans-Helmut König; Reiner Leidl; Ludger Staib; Karl-Heinrich Link
Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany.
PharmacoEconomics 2003;21(10):709-19.
2003: Marko Kornmann; Hans G Beger; Karl-Heinrich Link
Chemosensitivity testing and test-directed chemotherapy in human pancreatic cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2003;161():180-95.
2002: Marko Kornmann; Karl-Heinrich Link
Conversion of locally inoperable primary rectal cancer with multiple liver metastases to an option for cure after local down-staging and hepatic arterial infusion chemotherapy.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2002;387(2):90-3.
2002: Marko Kornmann; Karl-Heinrich Link; Inga Galuba; Kati Ott; Wolfgang Schwabe; Peter Häusler; Peter Scholz; Jörn Sträter; Sucan Polat; Bernhard Leibl; Erika Kettner; Christoph Schlichting; Wolfram Baumann; Harald Schramm; Ute Hecker; Karsten Ridwelski; Jürgen H Vogt; Klaus-Ullrich Zerbian; Frank Schütze; Ernst D Kreuser; Detlev Behnke; Hans G Beger
Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2002;6(3):331-7.
2002: L Staib; Karl-Heinrich Link; Doris Henne-Bruns
[Preoperative short-time radiotherapy in resectable rectal cancer: A "new standard" coming up?].
Zeitschrift für Gastroenterologie 2002;40(3):203-4.
2002: Ludger Staib; Karl-Heinrich Link; D Henne-Bruns
[Interferon-alpha in adjuvant treatment of colorectal carcinoma].
Kongressband / Deutsche Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 2002;119():142-5.
2002: Ludger Staib; Karl-Heinrich Link; Annette Blatz; Hans Günther Beger
Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients--monoinstitutional experience.
World journal of surgery 2002;26(1):59-66.
2001: Karl-Heinrich Link; E Sunelaitis; Marko Kornmann; Miriam Schatz; Frank Gansauge; Gerhard Leder; Andrea Formentini; Ludger Staib; J Pillasch; Hans G Beger
Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
Cancer 2001;92(11):2746-53.
2001: John P Neoptolemos; Janet A Dunn; Deborah D Stocken; J Almond; Karl-Heinrich Link; Hans Beger; Claudio Bassi; Massimo Falconi; Paolo Pederzoli; Christos Dervenis; Laureano Fernandez-Cruz; François Lacaine; A Pap; David Spooner; David J Kerr; Helmut Friess; Markus W Büchler
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
Lancet 2001;358(9293):1576-85.
2001: Karl-Heinrich Link
[Changes in therapy of resectable rectal carcinoma].
Der Internist 2001;42(6):910-2.
2001: Ludger Staib; Karl-Heinrich Link; Hans G Beger
Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2001;5(3):275-81.
2001: Karl-Heinrich Link; Ludger Staib; Marko Kornmann; Andrea Formentini; Miriam Schatz; P Suhr; PM Messer; Erwin M Röttinger; Hans G Beger
Surgery, radio- and chemotherapy for multimodal treatment of rectal cancer.
Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera 2001;7(6):256-74.
2000: Ludger Staib; Karl-Heinrich Link; Hans G Beger
Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2000;385(6):412-20.
2000: Marko Kornmann; H Fakler; U Butzer; Hans G Beger; Karl-Heinrich Link
Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
Anticancer research 2000;20(5A):3259-64.
2000: Marko Kornmann; U Butzer; J Blatter; Hans G Beger; Karl-Heinrich Link
Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(6):583-7.
2000: Karl-Heinrich Link; Marko Kornmann; U Butzer; Gerhard Leder; E Sunelaitis; J Pillasch; Dennis Salonga; KD Danenberg; PV Danenberg; Hans G Beger
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
Cancer 2000;89(2):288-96.
2000: Gerhard Leder; J Pillasch; Marko Kornmann; PV Danenberg; Karl-Heinrich Link
Theoretical considerations and in vitro concentration response studies with two human colorectal carcinoma cell lines. The rational experimental base for clinical studies in regional chemotherapy.
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(4):565-77.
1999: Hans G Beger; Frank Gansauge; Markus W Büchler; Karl-Heinrich Link
Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis.
World journal of surgery 1999;23(9):946-9.
1999: Ludger Staib; Karl-Heinrich Link; Hans G Beger
Immunotherapy in pancreatic cancer - current status and future.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 1999;384(4):396-404.
1999: Karl-Heinrich Link; Marko Kornmann; Andrea Formentini; Gerhard Leder; E Sunelaitis; Miriam Schatz; Jochen Pressmar; Hans G Beger
Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 1999;384(4):344-53.
1999: Karl-Heinrich Link; J Pillasch; Andrea Formentini; E Sunelaitis; Gerhard Leder; F Safi; Marko Kornmann; Hans G Beger
Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1999;25(4):381-8.
1999: N Warszawski; Karl-Heinrich Link; A Warszawski; Manfred P Lutz; Frank Gansauge; B M Schneider; Erwin M Röttinger
[Effect of therapy on survival of patients with pancreatic carcinoma].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1999;175(7):315-9.
1999: Frank Gansauge; Susanne Gansauge; Karl-Heinrich Link; H G Beger
p53 in relation to therapeutic outcome of locoregional chemotherapy in pancreatic cancer.
Annals of the New York Academy of Sciences 1999;880():281-7.
1999: C H J van Eijck; Karl-Heinrich Link; M E E van Rossen; Johannes Jeekel
(Neo)adjuvant treatment in pancreatic cancer--the need for future trials.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1999;25(2):132-7.
1999: Karl-Heinrich Link; Marko Kornmann; Gerhard Leder; A F Pillasch; E Sunelaitis; Miriam Schatz; Jochen Pressmar; Hans G Beger
Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(3):269-81.
1999: Karl-Heinrich Link; Gerhard Leder; Andrea Formentini; G Fortnagel; Marko Kornmann; Miriam Schatz; Hans G Beger
Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(1):10-40.
1998: J Reusch; A M Keck; Karl-Heinrich Link; H H Mohr
[The coexistence of 2 different neuroendocrine tumors of the upper gastrointestinal tract and pancreas].
Deutsche medizinische Wochenschrift (1946) 1998;123(49):1472-7.
1998: Karl-Heinrich Link; Ludger Staib; Miriam Schatz; P Suhr; Erwin M Röttinger; Hans G Beger
Adjuvant radiochemotherapy--what is the patients benefit?
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 1998;383(6):416-26.
1998: Karl-Heinrich Link; L Staib; Miriam Schatz; P Suhr; Erwin M Röttinger; Hans G Beger
Multimodal therapy in rectal cancer.
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(14):2167-92.
1998: Hans G Beger; Karl-Heinrich Link; Frank Gansauge
Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
Hepato-gastroenterology 1998;45(21):638-43.
1998: Karl-Heinrich Link; Andrea Formentini; Gerhard Leder; G Fortnagel; N Sartori; Miriam Schatz; Hans G Beger
Resection and radiochemotherapy of pancreatic cancer--the future?
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 1998;383(2):134-44.
1998: Karl-Heinrich Link; Gerhard Leder; J Pillasch; U Butzer; Ludger Staib; Marko Kornmann; Uwe B Bruckner; Hans G Beger
In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols.
Seminars in surgical oncology 1998;14(3):189-201.
1997: Karl-Heinrich Link; Frank Gansauge; Johannes Görich; Gerhard Leder; N Rilinger; Hans G Beger
Palliative and adjuvant regional chemotherapy in pancreatic cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1997;23(5):409-14.
1997: Marko Kornmann; Karl-Heinrich Link; H J Lenz; J Pillasch; R Metzger; U Butzer; Gerhard Leder; M Weindel; F Safi; KD Danenberg; Hans G Beger; PV Danenberg
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy.
Cancer letters 1997;118(1):29-35.
1997: Hans G Beger; MH Schoenberg; Karl-Heinrich Link; F Safi; D Berger
[Duodenum-preserving pancreatic head resection--a standard method in chronic pancreatitis].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1997;68(9):874-80.
1997: John P Neoptolemos; P Baker; H Beger; Karl-Heinrich Link; Paolo Pederzoli; Claudio Bassi; Christos Dervenis; Helmut Friess; Markus W Büchler
Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).
International journal of pancreatology : official journal of the International Association of Pancreatology 1997;21(2):97-104.
1997: Karl-Heinrich Link; Frank Gansauge; J Pillasch; Hans G Beger
Multimodal therapies in ductal pancreatic cancer. The future.
International journal of pancreatology : official journal of the International Association of Pancreatology 1997;21(1):71-83.
1997: Karl-Heinrich Link; Frank Gansauge; N Rilinger; Hans G Beger
Celiac artery adjuvant chemotherapy. Results of a prospective trial.
International journal of pancreatology : official journal of the International Association of Pancreatology 1997;21(1):65-9.
1997: John P Neoptolemos; David J Kerr; H Beger; Karl-Heinrich Link; Paolo Pederzoli; Claudio Bassi; Christos Dervenis; Laureano Fernandez-Cruz; F Laçaine; Helmut Friess; Markus W Büchler
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer.
Digestion 1997;58(6):570-7.
1997: Karl-Heinrich Link; Andrea Formentini; Frank Gansauge; E Papachristov; Hans G Beger
Regional celiac artery infusion as adjuvant treatment after pancreatic cancer resection.
Digestion 1997;58(6):529-32.
1996: Frank Gansauge; Susanne Gansauge; N Parker; M I Beger; Bertram Poch; Karl-Heinrich Link; F Safi; Hans G Beger
CAM 17.1--a new diagnostic marker in pancreatic cancer.
British journal of cancer 1996;74(12):1997-2002.
1996: Karl-Heinrich Link; Marko Kornmann; Gerhard Leder; U Butzer; J Pillasch; L Staib; Frank Gansauge; Hans G Beger
Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(9):1469-74.
1996: Karl-Heinrich Link; J Pillasch; M Weindel; Gerhard Leder; Hans G Beger
Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(11):1380.
1996: Frank Gansauge; Karl-Heinrich Link; N Rilinger; R Kunz; Hans G Beger
[Adjuvant regional chemotherapy in resected advanced pancreas carcinoma].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1996;67(4):362-5.
1996: Karl-Heinrich Link; L Staib; Ernst D Kreuser; Hans G Beger
Adjuvant treatment of colon and rectal cancer: impact of chemotherapy, radiotherapy, and immunotherapy on routine postsurgical patient management. Forschungsgruppe Onkologie Gastrointestinaler Tumoren (FOGT).
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;142():311-52.
1996: Karl-Heinrich Link; U Butzer; J Pillasch; G Hepp; Hans G Beger
In vitro pharmalogic rationale for intraperitoneal regional chemotherapy.
Cancer treatment and research 1996;82():101-14.
1996: Karl-Heinrich Link; G Hepp; L Staib; U Butzer; W Böhm; Hans G Beger
Intraperitoneal regional chemotherapy with mitroxantrone.
Cancer treatment and research 1996;81():31-40.
1996: Franz Porzsolt; A Wirth; R Mayer-Steinacker; Michael Schulte; G Negri; P Suhr; Karl-Heinrich Link; W Gaus; Erwin M Röttinger
Quality assurance by specification and achievement of goals in palliative cancer treatment.
Cancer treatment reviews 1996;22 Suppl A():41-9.
1995: Frank Gansauge; Susanne Gansauge; A Zobywalski; C Scharnweber; Karl-Heinrich Link; Andreas K Nussler; Hans G Beger
Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas.
Cancer research 1995;55(23):5499-503.
1995: Frank Gansauge; Karl-Heinrich Link; N Rilinger; R Kunz; Hans G Beger
[Regional chemotherapy in advanced pancreatic carcinoma].
Medizinische Klinik (Munich, Germany : 1983) 1995;90(9):501-5.
1993: F Safi; Karl-Heinrich Link; H G Beger
Is follow-up of colorectal cancer patients worthwhile?
Diseases of the colon and rectum 1993;36(7):636-43; discussion 643-4.
1992: J M Friedrich; P Schnarkowski; Karl-Heinrich Link; K A Schumacher; S Hoch
Flushable stent-system for internal drainage in occlusive jaundice.
European journal of radiology 1992;15(1):45-8.
1992: Karl-Heinrich Link; Hans G Beger
[What is confirmed in chemo- and immunotherapy of solid tumors. Standard protocols, studies and new developments].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1992;63(5):401-9.
1989: HOLGER VOIGT; K R Aigner; Karl-Heinrich Link; H Walther; H Müller
[Systemically administered regional tumor therapy. Regional hemi-body chemotherapy of metastatic malignant melanoma--an experimental therapy concept].
Onkologie 1989;12(6):280-4.
1989: Karl-Heinrich Link
[In vitro interaction of mezlocillin with fluorouracil and mitomycin].
Arzneimittel-Forschung 1989;39(11):1403-5.
1988: Karl-Heinrich Link; K R Aigner; K Peschau; M Warthona; Konrad Schwemmle; P V Danenberg
Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells.
Cancer chemotherapy and pharmacology 1988;22(1):58-62.
1987: K Schwemmle; Karl-Heinrich Link; B Rieck
Rationale and indications for perfusion in liver tumors: current data.
World journal of surgery 1987;11(4):534-40.
1986: Karl-Heinrich Link; K R Aigner; W Kuehn; K Schwemmle; D H Kern
Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases.
Cancer research 1986;46(9):4837-40.
1985: H Walther; K R Aigner; Karl-Heinrich Link; H J Helling; K Schwemmle
[Reduction of postoperative edema following isolated hyperthermic perfusion of the extremities with prophylactic administration of aprotinin. Preliminary results].
Arzneimittel-Forschung 1985;35(7):1065-9.
1984: K R Aigner; A Jungbluth; Karl-Heinrich Link; H Walther; H Müller; Konrad Schwemmle; T Ringenberg; G Börger; R Ruppel; L Illig
[Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
Onkologie 1984;7(6):348-53.
1984: K R Aigner; Karl-Heinrich Link; K Schwemmle
[Short intermittent arterial infusion in local chemotherapy of liver tumors and metastases].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1984;55(8):494-8.
1984: K R Aigner; H Walther; J C Tonn; Karl-Heinrich Link; P Schoch; K Schwemmle
[Isolated liver perfusion in advanced metastases of colorectal cancers].
Onkologie 1984;7(1):13-21.
1983: K R Aigner; Karl-Heinrich Link; H Woescher; W Johannes; M Hundeiker
Regional perfusion of VX 2 carcinoma with cis-DDP.
Anticancer research 1983;3(6):431-4.
1983: K H Muhrer; Karl-Heinrich Link
KCl carcinoma extracts as tumor antigens in the electrophoretic mobility test: clinical evaluation.
Cancer detection and prevention 1983;6(1-2):101-6.
1983: Karl-Heinrich Link; C Heidelberger; J R Landolph
Induction of ouabain-resistant mutants by chemical carcinogens in rat prostate epithelial cells.
Environmental mutagenesis 1983;5(1):33-48.
1982: Peter Hild; Karl-Heinrich Link
[Malignant sacrococcygeal teratoma in an adult].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1982;53(2):117-9.